News and Publications

NEWS

02/09/2022

Arkuda Therapeutics Raises $64 Million Series B Financing to Advance Pipeline of Programs Targeting Lysosomal Biology to Treat Neurodegenerative Diseases

Funding to support progression of lead progranulin enhancer program into IND-enabling studies Small molecule platform…

12/06/2021

Arkuda Therapeutics Awarded Michael J. Fox Foundation Grant to Accelerate Development of Compounds for Parkinson’s Disease

Watertown, MA – December 6, 2021 – Arkuda Therapeutics, a biotechnology company applying new insights at the inte…

03/24/2021

Arkuda Therapeutics to Participate in Stifel’s 3rd Annual CNS Day

Watertown, MA – March 25, 2021 – Arkuda Therapeutics, a biotechnology company applying new insights into lysosoma…

PUBLICATIONS

10/07/2021

DISCOVERY OF SMALL MOLECULES FOR THE TREATMENT OF PD-GBA

Natasha Khatri, Mary K. Wozniak, Jerusha K. Brendel, Anna-Maria Alves, Christopher J. Holler, James C. Lanter, Duane …

04/08/2020

DISCOVERY OF NOVEL SMALL MOLECULES FOR THE TREATMENT OF FTD-GRN

Christopher J. Holler, Angela Chen, Natasha Khatri, James C. Lanter, Ricardo L. Sanz, Jerusha K. Brendel, Mary Woznia…